1. "Human Oncology and Pathogenesis Program"
Formats
  1. Journal Article (2984)
  2. Meeting Abstract (2527)
  3. Review (137)
  4. Editorial (106)
  5. Book Section (54)
  6. Research Letter (41)
  7. Guidelines (18)
  8. Correspondence (16)
  9. Miscellaneous (15)
  10. Conference Paper (13)
  11. Book Whole (3)
Groups
  1. Human Oncology and Pathogenesis Program (5914)
  2. GSK Faculty (5697)
  3. Department of Medicine (4259)
  4. Department of Pathology and Laboratory Medicine (3037)
  5. Tow Center for Developmental Oncology (TCDO) (2613)
  6. Solid Tumor Oncology Division (2600)

More Groups

People
  1. Marc Ladanyi (1327)
  2. David Solit (779)
  3. Ross Levine (774)
  4. Michael Berger (765)
  5. Nikolaus Schultz (486)
  6. Maria Arcila (426)

More People

Years
  1. 2025 (120)
  2. 2024 (359)
  3. 2023 (402)
  4. 2022 (451)
  5. 2021 (380)
  6. 2020 (457)

More Years

Publications
  1. Journal of Clinical Oncology (636)
  2. Blood (495)
  3. Cancer Research (412)
  4. Modern Pathology (299)
  5. Clinical Cancer Research (268)
  6. Laboratory Investigation (263)

More Publications

Publishers
  1. American Association for Cancer Research (871)
  2. Nature Publishing Group (758)
  3. American Society of Clinical Oncology (702)
  4. American Society of Hematology (541)
  5. Elsevier Inc. (420)
  6. Nature Research (312)

More Publishers

Results (5914)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • 17-Allylamino-geldanamycin causes AKT inactivation and enhances the anti-tumor effects of paclitaxel
    Meeting Abstract

    Solit, D. B.; Basso, A. D.; Munster, P. N.; Norton, L.; Scher, H. I.; Rosen, N.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Phase I trial of 17AAG (17-allylamino) 17-demethoxygeldanamycin (17AAG) in patients (Pts) with advanced cancer
    Meeting Abstract

    Scher, H. I.; Solit, D. B.; Munster, P. N.; Tong, W. P.; Lawrence, S.; Kenneson, K.; Larson, S.; De La Cruz, A.; Reuter, V.; Rosen, N.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Histogenesis and molecular subclassification of Ewing's sarcoma using cDNA microarrays
    Meeting Abstract

    Wei, J. S.; Khan, J.; Ringnér, M.; Ladanyi, M.; Meltzer, P. S.
    Clinical Cancer Research (2001)

    Fulltext@MSK | Save
  • Biological and clinical impact of chromosomal translocations in childhood sarcomas
    Meeting Abstract

    Ladanyi, M.
    British Journal of Cancer (2001)

    Fulltext@MSK | Save
  • Genetic diversity of the killer cell immunoglobulin-like receptor genomic region
    Meeting Abstract

    Hsu, K. C.; Selvakumar, A.; Liu, X. R.; O'reilly, R.; Dupont, B.
    Blood (2001)

    Fulltext@MSK | Save
  • HER-kinase-directed therapy of prostate cancer
    Journal Article

    Solit, D. B.; Agus, D. B.
    Prostate Journal (2001)

    Fulltext@MSK | Save
  • Correspondence Re: O'Sullivan MJ, Kyriakos M, Zhu X, Wick MR, Swanson PE, Dehner LP, Humphrey PA, Pfeifer JD: Malignant peripheral nerve sheath tumors with T(X;18). A pathologic and molecular genetic study. Mod Pathol 2000;13:1336–46
    Journal Article

    Ladanyi, M.; Woodruff, J. M.; Scheithauer, B. W.; Bridge, J. A.; Barr, F. G.; Goldblum, J. R.; Fisher, C.; Perez-Atayde, A.; Dal Cin, P.; Fletcher, C. D. M.; more...
    Modern Pathology (2001)

    Fulltext@MSK | Save
  • Diagnostic gold standard for soft tissue tumours: Morphology or molecular genetics?
    Journal Article

    Fletcher, C. D. M.; Fletcher, J. A.; Cin, P. D.; Ladanyi, M.; Woodruff, J. M.
    Histopathology (2001)

    Fulltext@MSK | Save
  • Fusions of the SYT and SSX genes in synovial sarcoma
    Journal Article

    Ladanyi, M.
    Oncogene (2001)

    Fulltext@MSK | Save
  • High-dose melphalan, etoposide, total-body irradiation, and autologous stem-cell reconstitution as consolidation therapy for high-risk Ewing's sarcoma does not improve prognosis
    Journal Article

    Meyers, P. A.; Krailo, M. D.; Ladanyi, M.; Chan, K. W.; Sailer, S. L.; Dickman, P. S.; Baker, D. L.; Davis, J. H.; Gerbing, R. B.; Grovas, A.; more...
    Journal of Clinical Oncology (2001)

    Fulltext@MSK | Save